Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | PIM1 | P11309 | 1/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.44 |
| ▸ | FLT1 | P17948 | 1/20 | 0.44 |
| ▸ | GRK5 | P34947 | 1/20 | 0.44 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.44 |
| ▸ | CDK8 | P49336 | 1/20 | 0.44 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.44 |
| ▸ | PRKX | P51817 | 1/20 | 0.44 |
| ▸ | JAK3 | P52333 | 1/20 | 0.44 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.44 |
| ▸ | BTK | Q06187 | 1/20 | 0.44 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.44 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.44 |
| ▸ | CAMK1D | Q8IU85 | 1/20 | 0.44 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL11709595 | 1.00 | CHEK1 (0.44) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| SCHEMBL29357116 | 0.95 | CHEK1 (0.48) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| SCHEMBL29758423 | 0.95 | CHEK1 (0.48) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| SCHEMBL2801169 | 0.95 | CHEK1 (0.48) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| 1,4-Butanediol SCHEMBL11709268 | 0.94 | CHEK1 (0.43) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| 1,3-Propanediol SCHEMBL11708184 | 0.94 | CHEK1 (0.43) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| Glycolic Acid SCHEMBL5562280 | 0.94 | CHEK1 (0.44) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| 1,6-Hexanediol SCHEMBL11706008 | 0.93 | CHEK1 (0.42) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| Ethylene SCHEMBL6266470 | 0.92 | CHEK1 (0.46) | CHEK1FYNPDGFRBPIM1FGFR1 | |
| SCHEMBL11536950 | 0.86 | PTGDR2 (0.42) | CHEK1FYNPDGFRBPIM1FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 498 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1253169-B1 | Degradation inhibitor for resin material, chlorine water-resistant resin composition and method for inhibiting degradation | API CORP (JP) | 2006-03-15 | — | — | EP | claimed |
| EP-0114028-B1 | COLOUR-PHOTOGRAPHIC RECORDING MATERIAL | CIBA-GEIGY AG (CH) | 1988-08-03 | — | — | EP | claimed |
| US-12637567-B2 | Styrene-based resin composition | IDEMITSU KOSAN CO., LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-3941970-B1 | UV CURABLE COMPOSITIONS FOR DIRT PICK-UP RESISTANCE | BASF SE (DE) | 2025-10-15 | — | — | EP | disclosed |
| US-12426670-B2 | Midsole structure of an article of footwear including mesh | NIKE, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4008210-B1 | A KNIT TEXTILE | NIKE INNOVATE CV (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12342902-B2 | Footwear sole structure having a composite element and methods for manufacturing same | NIKE, INC. (US) | 2025-07-01 | — | — | US | disclosed |
| EP-3538699-B1 | KNIT ARTICLES AND PROCESSES FOR MAKING THE SAME | NIKE INNOVATE CV (US) | 2025-05-07 | — | — | EP | disclosed |
| US-12269208-B2 | Methods of manufacturing articles utilizing foam particles | NIKE, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| EP-3847220-B1 | UV-CURABLE HOT MELT ADHESIVE COMPOSITIONS FOR FLOORING APPLICATIONS | BASF SE (DE) | 2025-03-05 | — | — | EP | disclosed |
| EP-4008211-B1 | A TEXTILE AND A THERMOFORMED ARTICLE AND METHOD OF MANUFACTURING THE TEXTILE | NIKE INNOVATE CV (US) | 2025-02-26 | — | — | EP | disclosed |
| WO-1995006651-A1 | HYDROLYTICALLY STABLE PENTAERYTHRITOL DIPHOSPHITES | DOVER CHEMICAL CORPORATION (US) | 1995-03-09 | — | — | WO | disclosed |
| US-5395890-A | Styrene-based resin composition | IDEMITSU KOSAN CO., LTD. (JP) | 1995-03-07 | — | — | US | disclosed |
| US-5357014-A | High crystallinity, excellent in heat resistance, solvent resistance and transparency | IDEMITSU KOSAN CO., LTD. (JP) | 1994-10-18 | — | — | US | disclosed |
| EP-0531705-A2 | Styrenic resin molding and process for producing same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
| EP-0307488-B1 | A POLYSTYRENE-BASED RESIN COMPOSITION | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-07-22 | — | — | EP | disclosed |
| EP-0410934-A2 | Piperazine-piperidine compounds for use as stabilizers for organic materials | CIBA-GEIGY AG (CH) | 1991-01-30 | — | — | EP | disclosed |
| EP-0376889-A1 | Lubricating composition | CIBA-GEIGY AG (CH) | 1990-07-04 | — | — | EP | disclosed |
| EP-0307488-A1 | A polystyrene-based resin composition | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1989-03-22 | — | — | EP | disclosed |
| US-4578410-A | PHOTOSTABILIZERS, REACTING SORBITOL AND A TRIACETONAMINE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637567-B2 | Styrene-based resin composition | ARCN1, MLST8, ASIC1 | CHEK1 3934/4885FYN 2894/4885PDGFRB 1878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.